| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 3.35e-04 | 8 | 70 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.35e-04 | 10 | 70 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 7.19e-04 | 50 | 70 | 3 | GO:0004864 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 8.53e-04 | 210 | 70 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 9.00e-04 | 54 | 70 | 3 | GO:0019212 | |
| GeneOntologyMolecularFunction | profilin binding | 9.22e-04 | 13 | 70 | 2 | GO:0005522 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 2.04e-05 | 16 | 71 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | tight junction | 1.11e-04 | 139 | 71 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.24e-04 | 75 | 71 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | super elongation complex | 1.69e-04 | 6 | 71 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.84e-04 | 107 | 71 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.84e-04 | 107 | 71 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | methyltransferase complex | 5.02e-04 | 108 | 71 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | actomyosin | 6.78e-04 | 117 | 71 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 7.00e-04 | 118 | 71 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | cell-cell junction | 8.65e-04 | 591 | 71 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | nuclear body | 9.10e-04 | 903 | 71 | 10 | GO:0016604 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.03e-03 | 131 | 71 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.40e-03 | 360 | 71 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | anchoring junction | OCEL1 TJP1 SIPA1L3 CCDC85C PRKAR2A SRCIN1 PANX2 CLDN23 PTK2 ADD1 | 1.63e-03 | 976 | 71 | 10 | GO:0070161 |
| GeneOntologyCellularComponent | apical junction complex | 2.06e-03 | 158 | 71 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.37e-03 | 576 | 71 | 7 | GO:0015629 | |
| GeneOntologyCellularComponent | inclusion body | 3.57e-03 | 90 | 71 | 3 | GO:0016234 | |
| Domain | TF_AF4/FMR2 | 7.80e-05 | 4 | 68 | 2 | IPR007797 | |
| Domain | AF-4 | 7.80e-05 | 4 | 68 | 2 | PF05110 | |
| Domain | PDZ | 2.24e-04 | 151 | 68 | 5 | PS50106 | |
| Domain | PDZ | 2.31e-04 | 152 | 68 | 5 | IPR001478 | |
| Domain | MIT | 5.77e-04 | 10 | 68 | 2 | SM00745 | |
| Domain | MIT | 5.77e-04 | 10 | 68 | 2 | PF04212 | |
| Domain | Hairy_orange | 8.42e-04 | 12 | 68 | 2 | PF07527 | |
| Domain | Orange_dom | 8.42e-04 | 12 | 68 | 2 | IPR003650 | |
| Domain | ORANGE | 9.93e-04 | 13 | 68 | 2 | PS51054 | |
| Domain | MIT | 1.16e-03 | 14 | 68 | 2 | IPR007330 | |
| Domain | Post-SET_dom | 1.52e-03 | 16 | 68 | 2 | IPR003616 | |
| Domain | PostSET | 1.52e-03 | 16 | 68 | 2 | SM00508 | |
| Domain | POST_SET | 1.52e-03 | 16 | 68 | 2 | PS50868 | |
| Domain | - | 2.18e-03 | 150 | 68 | 4 | 2.30.42.10 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.54e-05 | 42 | 51 | 4 | M48018 | |
| Pubmed | KMT2D GTF3C1 TJP1 PHACTR4 NFKBIE BAG3 YLPM1 CCDC85C RPRD2 HCFC1 ADD1 PRRC2B HTT | 8.27e-11 | 549 | 71 | 13 | 38280479 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2D SETD1B ZNF48 SEMA7A ADAMTS7 BICRA CASKIN1 GRK5 SIPA1L3 HELZ2 CABIN1 HCFC1 ADCY7 CLDN23 PRRC2B HTT | 6.01e-10 | 1105 | 71 | 16 | 35748872 |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.13e-07 | 22 | 71 | 4 | 26886794 | |
| Pubmed | IRF2BP2 KMT2D TCF7L2 GTF3C1 BICRA ATF7IP SUPT7L NFKBIE YLPM1 CCDC85C RPRD2 CABIN1 GARRE1 HCFC1 PRRC2B | 1.57e-07 | 1429 | 71 | 15 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYPOP KMT2D TCF7L2 ZNF48 GTF3C1 SUPT7L HES7 YLPM1 RPRD2 CBX4 CDC6 CABIN1 HCFC1 STT3B | 3.01e-07 | 1294 | 71 | 14 | 30804502 |
| Pubmed | BOD1 TJP1 SIPA1L3 NFKBIE BAG3 CCDC85C PRKAR2A HS1BP3 CDC6 PRRC2B NUP35 STT3B | 8.65e-07 | 1007 | 71 | 12 | 34597346 | |
| Pubmed | 1.30e-06 | 268 | 71 | 7 | 33640491 | ||
| Pubmed | 1.77e-06 | 12 | 71 | 3 | 27563068 | ||
| Pubmed | 2.10e-06 | 288 | 71 | 7 | 23383273 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.18e-06 | 184 | 71 | 6 | 32908313 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 2.25e-06 | 565 | 71 | 9 | 25468996 | |
| Pubmed | 3.42e-06 | 50 | 71 | 4 | 37974198 | ||
| Pubmed | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | 3.64e-06 | 15 | 71 | 3 | 14672936 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDKN1B IRF2BP2 KMT2D GTF3C1 PHACTR4 BAG3 YLPM1 HELZ2 AFF1 ADD1 | 3.82e-06 | 774 | 71 | 10 | 15302935 |
| Pubmed | PRR36 TJP1 ATF7IP CASKIN1 SIPA1L3 YLPM1 PRKAR2A CABIN1 PTK2 ADD1 PRRC2B | 3.89e-06 | 963 | 71 | 11 | 28671696 | |
| Pubmed | Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. | 4.11e-06 | 2 | 71 | 2 | 16391524 | |
| Pubmed | Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. | 4.11e-06 | 2 | 71 | 2 | 21796119 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 35218185 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 1284592 | ||
| Pubmed | Unraveling the Role of Huntingtin in Breast Cancer Metastasis. | 4.11e-06 | 2 | 71 | 2 | 26293574 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LCA5 MAST4 TJP1 CAPN7 SIPA1L3 PHACTR4 NFKBIE CCDC85C GARRE1 PRRC2B | 8.93e-06 | 853 | 71 | 10 | 28718761 |
| Pubmed | Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study. | 1.23e-05 | 3 | 71 | 2 | 29514624 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 15557280 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18006506 | ||
| Pubmed | PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment. | 1.23e-05 | 3 | 71 | 2 | 28103122 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 37313815 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 30452683 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25274820 | ||
| Pubmed | BAG3 regulates formation of the SNARE complex and insulin secretion. | 1.23e-05 | 3 | 71 | 2 | 25766323 | |
| Pubmed | Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. | 1.23e-05 | 3 | 71 | 2 | 12700764 | |
| Pubmed | 1.76e-05 | 399 | 71 | 7 | 35987950 | ||
| Pubmed | 1.82e-05 | 25 | 71 | 3 | 19389377 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 TJP1 ATF7IP BAG3 YLPM1 CCDC85C RPRD2 HCFC1 ADD1 PRRC2B | 1.95e-05 | 934 | 71 | 10 | 33916271 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDKN1B GTF3C1 TJP1 GORASP1 SIPA1L3 YLPM1 CCDC85C PRKAR2A CDC6 HCFC1 PRRC2B | 2.13e-05 | 1155 | 71 | 11 | 20360068 |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 23974956 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 16705171 | ||
| Pubmed | Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells. | 2.46e-05 | 4 | 71 | 2 | 18458079 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 26231217 | ||
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 2.46e-05 | 4 | 71 | 2 | 11923441 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 2.46e-05 | 4 | 71 | 2 | 15459319 | |
| Pubmed | Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. | 2.46e-05 | 4 | 71 | 2 | 10531067 | |
| Pubmed | 2.76e-05 | 591 | 71 | 8 | 15231748 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.83e-05 | 430 | 71 | 7 | 35044719 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 3.52e-05 | 31 | 71 | 3 | 20516061 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 27232975 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 12473661 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 22613727 | ||
| Pubmed | p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. | 4.09e-05 | 5 | 71 | 2 | 17525734 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 20540670 | ||
| Pubmed | Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy. | 4.09e-05 | 5 | 71 | 2 | 25018096 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 14981075 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 28624440 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF7L2 GTF3C1 TJP1 BICRA SIPA1L3 CCDC85C AFF1 RPRD2 SRCIN1 PTK2 HTT SOS2 | 4.47e-05 | 1489 | 71 | 12 | 28611215 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.31e-05 | 475 | 71 | 7 | 31040226 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 6.00e-05 | 202 | 71 | 5 | 33601422 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 17342473 | ||
| Pubmed | Non-cell autonomous and non-catalytic activities of ATX in the developing brain. | 6.13e-05 | 6 | 71 | 2 | 25788872 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.32e-05 | 861 | 71 | 9 | 36931259 | |
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 6.77e-05 | 106 | 71 | 4 | 31024071 | |
| Pubmed | 7.84e-05 | 347 | 71 | 6 | 17114649 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 35429490 | ||
| Pubmed | A genome-wide survey on basic helix-loop-helix transcription factors in rat and mouse. | 8.57e-05 | 7 | 71 | 2 | 19306043 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 11152656 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 19598246 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 8.60e-05 | 218 | 71 | 5 | 33378226 | |
| Pubmed | 1.06e-04 | 119 | 71 | 4 | 23508102 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.13e-04 | 231 | 71 | 5 | 16452087 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 32479599 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 19933700 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.14e-04 | 8 | 71 | 2 | 23130995 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 22266653 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 20335362 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 7959767 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 38095908 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 22665483 | ||
| Pubmed | FGF signaling patterns cell fate at the interface between tendon and bone. | 1.47e-04 | 9 | 71 | 2 | 31320326 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 19820184 | ||
| Pubmed | RPGRIP1 MYPOP GTF3C1 TJP1 PCLO GRK5 SIPA1L3 YLPM1 PRRC2B NUP35 STT3B | 1.56e-04 | 1442 | 71 | 11 | 35575683 | |
| Pubmed | 1.61e-04 | 568 | 71 | 7 | 37774976 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.68e-04 | 134 | 71 | 4 | 25452129 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.82e-04 | 137 | 71 | 4 | 37039823 | |
| Pubmed | Hesr1 and Hesr2 may act as early effectors of Notch signaling in the developing cochlea. | 1.83e-04 | 10 | 71 | 2 | 18291358 | |
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 17998332 | ||
| Pubmed | Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. | 1.83e-04 | 10 | 71 | 2 | 18838538 | |
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 19000783 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 25733872 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 22056358 | ||
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 2.20e-04 | 57 | 71 | 3 | 23080069 | |
| Pubmed | Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development. | 2.23e-04 | 11 | 71 | 2 | 18302773 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 20346937 | ||
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 2.23e-04 | 11 | 71 | 2 | 29751817 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 17611704 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 15050687 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 26839363 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 15342473 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 25535395 | ||
| Pubmed | Dll3 is expressed in developing hair cells in the mammalian cochlea. | 2.68e-04 | 12 | 71 | 2 | 17823936 | |
| Pubmed | The period of the somite segmentation clock is sensitive to Notch activity. | 2.68e-04 | 12 | 71 | 2 | 21795391 | |
| Pubmed | Expression of Notch signaling pathway genes in mouse embryos lacking beta4galactosyltransferase-1. | 2.68e-04 | 12 | 71 | 2 | 16412699 | |
| Pubmed | 2.71e-04 | 152 | 71 | 4 | 38360978 | ||
| Interaction | WWTR1 interactions | KMT2D GTF3C1 TJP1 PHACTR4 NFKBIE BAG3 CCDC85C RPRD2 HCFC1 PRRC2B NUP35 HTT | 2.16e-08 | 422 | 70 | 12 | int:WWTR1 |
| Interaction | ENTR1 interactions | 4.01e-06 | 188 | 70 | 7 | int:ENTR1 | |
| Interaction | HNF1B interactions | 4.30e-06 | 190 | 70 | 7 | int:HNF1B | |
| Interaction | WDR82 interactions | 9.10e-06 | 213 | 70 | 7 | int:WDR82 | |
| Interaction | TOP3B interactions | KMT2D SETD1B ZNF48 SEMA7A ADAMTS7 BICRA CASKIN1 GRK5 SIPA1L3 HELZ2 CABIN1 HCFC1 ADCY7 CLDN23 PRRC2B HTT | 3.39e-05 | 1470 | 70 | 16 | int:TOP3B |
| Interaction | PAX6 interactions | 3.88e-05 | 366 | 70 | 8 | int:PAX6 | |
| Interaction | VASP interactions | 7.15e-05 | 294 | 70 | 7 | int:VASP | |
| Interaction | YWHAG interactions | CDKN1B LCA5 SPAST MAST4 TJP1 GRK5 SIPA1L3 PHACTR4 BAG3 CCDC85C CBX4 GARRE1 PTK2 HTT | 8.34e-05 | 1248 | 70 | 14 | int:YWHAG |
| Interaction | SP7 interactions | 8.82e-05 | 304 | 70 | 7 | int:SP7 | |
| Interaction | PCLO interactions | 1.03e-04 | 70 | 70 | 4 | int:PCLO | |
| Interaction | AMPH interactions | 1.15e-04 | 72 | 70 | 4 | int:AMPH | |
| Interaction | SMG7 interactions | 1.19e-04 | 319 | 70 | 7 | int:SMG7 | |
| Interaction | SIAH1 interactions | 1.25e-04 | 223 | 70 | 6 | int:SIAH1 | |
| Interaction | CNOT7 interactions | 1.27e-04 | 140 | 70 | 5 | int:CNOT7 | |
| Interaction | SETD1B interactions | 1.35e-04 | 75 | 70 | 4 | int:SETD1B | |
| Interaction | PPP1CA interactions | IRF2BP2 PHACTR4 YLPM1 CCDC85C PRKAR2A RPRD2 WDFY4 HCFC1 PTK2 HTT | 1.38e-04 | 696 | 70 | 10 | int:PPP1CA |
| Interaction | UBN1 interactions | 1.49e-04 | 77 | 70 | 4 | int:UBN1 | |
| Interaction | NCOA6 interactions | 1.50e-04 | 145 | 70 | 5 | int:NCOA6 | |
| Interaction | HEYL interactions | 1.68e-04 | 31 | 70 | 3 | int:HEYL | |
| Interaction | YWHAB interactions | CDKN1B LCA5 MAST4 TJP1 GRK5 SIPA1L3 PHACTR4 BAG3 CCDC85C CBX4 GARRE1 HTT | 1.76e-04 | 1014 | 70 | 12 | int:YWHAB |
| Interaction | CLTA interactions | 2.14e-04 | 351 | 70 | 7 | int:CLTA | |
| Interaction | ASF1A interactions | 2.27e-04 | 249 | 70 | 6 | int:ASF1A | |
| Interaction | MEF2D interactions | 2.39e-04 | 87 | 70 | 4 | int:MEF2D | |
| Interaction | CRYBA4 interactions | 2.43e-04 | 35 | 70 | 3 | int:CRYBA4 | |
| Cytoband | 22q13.33 | 1.60e-03 | 38 | 71 | 2 | 22q13.33 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.62e-05 | 4 | 45 | 2 | 1145 | |
| GeneFamily | PDZ domain containing | 3.66e-05 | 152 | 45 | 5 | 1220 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.16e-04 | 9 | 45 | 2 | 1280 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.05e-03 | 181 | 45 | 4 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.23e-03 | 34 | 45 | 2 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.62e-03 | 36 | 45 | 2 | 823 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP | 1.19e-06 | 200 | 71 | 7 | M7195 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 1.69e-05 | 199 | 71 | 6 | M7711 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.69e-05 | 199 | 71 | 6 | M9124 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN | 1.74e-05 | 200 | 71 | 6 | M7796 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SETD1B BICRA PHACTR4 CACNA1I CBX4 C1orf162 GARRE1 HCFC1 ADCY7 | 5.24e-05 | 634 | 71 | 9 | M40866 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 6.85e-05 | 157 | 71 | 5 | M7733 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TCF7L2 TJP1 ATF7IP BAG3 HS1BP3 GARRE1 HECA ADCY7 PRRC2B SOS2 | 7.13e-05 | 822 | 71 | 10 | M6782 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-07 | 174 | 71 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 178 | 71 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 188 | 71 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 190 | 71 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.23e-06 | 194 | 70 | 7 | 4727_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 6240_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 5431_DN | |
| Drug | NSC 97945 | 1.51e-05 | 16 | 70 | 3 | CID000097054 | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A | 2.40e-05 | 187 | 70 | 6 | 1565_UP | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A | 2.40e-05 | 187 | 70 | 6 | 2571_UP | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.87e-05 | 193 | 70 | 6 | 4978_UP | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.87e-05 | 193 | 70 | 6 | 2828_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 2.87e-05 | 193 | 70 | 6 | 5608_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 4643_UP | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 3580_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 1687_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 2125_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 4145_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 5488_UP | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 3970_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 5604_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 5642_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 3936_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 1487_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 4160_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 1810_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 7194_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3931_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 7037_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 7358_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7375_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 3292_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6765_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7174_DN | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 4947_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6343_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 2786_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6043_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 3882_DN | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 3449_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 4691_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 4774_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 6283_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 3.50e-05 | 200 | 70 | 6 | 665_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 3896_DN | |
| Drug | 7B-forskolin | 6.88e-05 | 26 | 70 | 3 | CID000130638 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.99e-04 | 174 | 70 | 5 | 1302_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.16e-04 | 177 | 70 | 5 | 4652_DN | |
| Drug | Calpain inhibitor I | 2.22e-04 | 280 | 70 | 6 | CID000004332 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.52e-04 | 183 | 70 | 5 | 5613_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.52e-04 | 183 | 70 | 5 | 4843_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.71e-04 | 186 | 70 | 5 | 6051_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.78e-04 | 187 | 70 | 5 | 5233_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.92e-04 | 189 | 70 | 5 | 5248_DN | |
| Drug | wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 189 | 70 | 5 | 869_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 2189_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 6933_UP | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 6162_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 6958_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 5206_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 2283_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 7147_UP | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 2894_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5384_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2469_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7221_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 6467_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4411_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5229_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4573_UP | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; PC3; HG-U133A | 3.30e-04 | 194 | 70 | 5 | 1954_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 1179_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 3454_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 6811_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4358_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 3.37e-04 | 195 | 70 | 5 | 449_UP | |
| Drug | 5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA | 3.37e-04 | 195 | 70 | 5 | 908_DN | |
| Drug | 5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA | 3.37e-04 | 195 | 70 | 5 | 898_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 2426_UP | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3470_DN | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4418_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3298_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5428_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4155_DN | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 2796_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3714_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5297_UP | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3181_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 3.37e-04 | 195 | 70 | 5 | 1886_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5626_DN | |
| Drug | AC1L1IZ2 | 3.45e-04 | 304 | 70 | 6 | CID000004795 | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2440_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3217_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 6286_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 7226_DN | |
| Drug | radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 493_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4423_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 1686_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2119_DN | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 7175_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 7496_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 1685_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4724_UP | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 6295_DN | |
| Disease | household income | 7.91e-05 | 304 | 69 | 6 | EFO_0009695 | |
| Disease | cortical thickness | LMAN1L IRF2BP2 TCF7L2 MAST4 ADAMTS7 YLPM1 PRKAR2A AFF1 FOXC2 SOS2 | 2.52e-04 | 1113 | 69 | 10 | EFO_0004840 |
| Disease | Antihypertensive use measurement | 3.96e-04 | 265 | 69 | 5 | EFO_0009927 | |
| Disease | lung small cell carcinoma (is_marker_for) | 6.33e-04 | 16 | 69 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Leber congenital amaurosis | 6.33e-04 | 16 | 69 | 2 | cv:C0339527 | |
| Disease | intellectual disability (implicated_via_orthology) | 7.33e-04 | 75 | 69 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Hydrops Fetalis | 8.98e-04 | 19 | 69 | 2 | C0020305 | |
| Disease | hydrocephalus (implicated_via_orthology) | 8.98e-04 | 19 | 69 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 1.10e-03 | 21 | 69 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | Nystagmus | 1.10e-03 | 21 | 69 | 2 | HP_0000639 | |
| Disease | Leber Congenital Amaurosis | 1.21e-03 | 22 | 69 | 2 | C0339527 | |
| Disease | Sezary Syndrome | 1.82e-03 | 27 | 69 | 2 | C0036920 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.93e-03 | 105 | 69 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | unipolar depression, irritable bowel syndrome | 1.96e-03 | 28 | 69 | 2 | EFO_0000555, EFO_0003761 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.96e-03 | 28 | 69 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | longevity, healthspan, parental longevity | 2.10e-03 | 29 | 69 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HHRPDPHPPAPGKKK | 41 | A8MWP4 | |
| PHPPAPGKKKSSPVG | 46 | A8MWP4 | |
| PIPQRLGGPAPKAHP | 301 | Q8IZL9 | |
| CPEKAPPPQKPSHEG | 56 | Q6UWT2 | |
| PPRGRNKATAHKPAP | 666 | P51816 | |
| PPPSQHLPRPKGDAA | 461 | P51828 | |
| PPRPPKGACKVPAQE | 91 | P46527 | |
| GPAKPPAHRPCGAQP | 1506 | Q9UKP4 | |
| REKSAPEPPPPGKHS | 91 | Q8N436 | |
| PRPPCQPQPGPHKAK | 96 | Q9H607 | |
| PIGAIPKGHKPRPHP | 131 | Q9H607 | |
| KTPKNGPPPCPRLGH | 126 | P51610 | |
| KRAHGTPPPVSPKPP | 1261 | Q8WXD9 | |
| AKPPSPGAPALHVPA | 1326 | Q8WXD9 | |
| PGAPALHVPAKPPRA | 1331 | Q8WXD9 | |
| RPPNKPQKGPSHDLP | 226 | Q9UBI9 | |
| AKAAAKAPRPPGQPP | 441 | Q9HAT1 | |
| PCTHPPGPVKEPQEK | 186 | O00221 | |
| PLLPPGPHKAPDGKA | 226 | A6NKD9 | |
| HEKSQPGPAKPPAQP | 321 | Q9Y6V0 | |
| HHQAPRKPSPKGLPN | 61 | Q86VQ0 | |
| AHLKEPPPAASKGAP | 181 | Q99958 | |
| KQPPIPPPKPAHRNS | 256 | Q8IZ21 | |
| RIPTQPPSYHKKPPG | 201 | Q9BQQ3 | |
| RPAAPKAGPPGLVHP | 171 | Q02080 | |
| PGPAVAEEPLHRPKK | 76 | P42858 | |
| PRKPAVPPKAGPAEA | 341 | Q53T59 | |
| LSSRHKNPAPPEGKP | 106 | Q96GS4 | |
| PPEGHPGKPEPSRAK | 2111 | Q9Y6J0 | |
| VKPKPPPVRAHFPLG | 166 | Q9Y6W3 | |
| PGSFLKPPAPPVQHE | 281 | Q8NHY3 | |
| KKAAVPAPPPEPEGQ | 161 | Q96IK1 | |
| APAPAKPGPHAKEPR | 471 | Q9P0X4 | |
| PPPPAHKAAPKGFKA | 1041 | O15063 | |
| QPHSKERAGKPPPPG | 131 | O00257 | |
| NTPHLPPCSPPKQGK | 66 | Q99741 | |
| KKRHEHPPNPPVSPG | 661 | Q6VMQ6 | |
| KTNHKDGPGEARPPP | 2041 | O15021 | |
| KGKDPAPAQPPPARK | 2561 | O15021 | |
| HPPPEPGPDRVADAK | 61 | P13861 | |
| ERSPHPPQEVKDPPG | 256 | P0DO97 | |
| KGNPIHARGKVPPHP | 761 | Q9BYK8 | |
| DLNRNHPPEPPKKGL | 536 | P34947 | |
| PPPHRQDGAPKAPLP | 201 | Q9BYE0 | |
| TPPKPGEAEAPPKHP | 406 | O95817 | |
| GTVDHPPPAAPERKP | 1361 | Q9NZM4 | |
| KPQAPDPHSDPPAKL | 96 | Q8NEQ5 | |
| KEAALAHAAPPPPPG | 1246 | Q5VT52 | |
| AKEKQPPPPAHRGPA | 256 | Q7Z5L9 | |
| DGQHRPPPAQHRKPK | 226 | Q96B33 | |
| APAPAPPPAPDKKHA | 496 | Q96RD6 | |
| QPVVPAHKDKSGAPP | 76 | Q8NFH5 | |
| HTAGAPVPEKPKRGP | 151 | Q96KN7 | |
| PPPLPPRKKFDHDAS | 1146 | Q07890 | |
| KPGNLSRPPPVVVPH | 486 | Q9BU23 | |
| APPKKPPRPGAPGHL | 871 | Q05397 | |
| GTPRAPAHPSQPKPK | 261 | Q9H6K5 | |
| AKAPRPAKPHKPPGS | 1326 | O60292 | |
| PKKRHEDLVPPAGSP | 1646 | Q9UPS6 | |
| AGPAPPPESPHKRNL | 36 | Q9UBP0 | |
| DPPLHQPSANKPKPP | 36 | O94864 | |
| PAAPAKEPKAPGAAP | 126 | Q5TA89 | |
| PRAPPEAPHPGKRSC | 571 | P51825 | |
| QKEKSPPDQPAVPHP | 596 | P35611 | |
| PPPPLAGDKPHKCPE | 441 | Q96MX3 | |
| PPKAPHGQKAAPRTE | 966 | Q9C0H9 | |
| AHKAAGGAAPPKPAP | 41 | Q8TCJ2 | |
| PADVDPKTGIPRPPH | 221 | Q9NQB0 | |
| KPHPARTAAGKPLPG | 2816 | Q6ZS81 | |
| RKAPDPQPPPRKLHG | 446 | Q5JSZ5 | |
| EPHKECPNPKPDKAP | 536 | O75326 | |
| SHQPPPAPRVEKKPE | 1801 | P49750 | |
| LRPEAQPHPSAGPKP | 1171 | Q07157 | |
| PKKHHLDPVPPAGNS | 996 | P52746 | |
| HPLKKQPPSFPGAAE | 526 | Q12789 | |
| LHKPPRPQPPEVAFK | 2466 | O14686 | |
| GDRFVIPPHPKVPAP | 596 | Q9P206 | |
| APLPPHDSPPHKRRK | 371 | Q86VE0 |